Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in patients with hypertension and left ventricular hypertrophy? The LIFE study

被引：0
|
作者：
Ibsen, H
Olsen, MH
Wachtell, K
Borch-Johnsen, K
Lindholm, L
Dahlof, B
Snapinn, S
机构：
[1] Glostrup Cty Hosp, Glostrup, Denmark
[2] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[3] Umea Univ, Umea, Sweden
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Merck, W Point, PA USA
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [1] Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy?: A LIFE substudy
    Ibsen, H
    Wachtell, K
    Olsen, MH
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Devereux, RB
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wan, Y
    JOURNAL OF HYPERTENSION, 2004, 22 (09) : 1805 - 1811
  • [2] Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy?: The LIFE study
    Ibsen, H
    Olsen, MH
    Wachtell, K
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Snapinn, SM
    Wan, Y
    Lyle, PA
    DIABETES CARE, 2006, 29 (03) : 595 - 600
  • [3] Albuminuria predicts cardiovascular outcome on treatment with losartan versus atenolol in patients with diabetes, hypertension and left ventricular hypertrophy?: A life diabetes substudy
    Ibsen, H
    Olsen, MH
    Wachtell, K
    Borch-Johnsen, K
    Lindholm, L
    Dahlöf, B
    Snapinn, S
    JOURNAL OF HYPERTENSION, 2004, 22 : S64 - S64
  • [4] Albuminuria predicts cardiovascular outcome with losartan versus atenolol in patients with diabetes, hypertension and left ventricular hypertrophy. A life diabetes substudy
    Ibsen, H
    Olsen, MH
    Wachtell, K
    Borch-Johnsen, K
    Lindholm, L
    Dahloef, B
    Snapinn, S
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 2A - 2A
  • [5] Female sex and effect of Losartan versus atenolol in patients with hypertension and left ventricular hypertrophy. The LIFE study
    Os, I
    Oparil, S
    Kjeldsen, SE
    Gerdts, E
    Hille, DA
    Lyle, PA
    Fouad-Tarazi, F
    Dahlof, B
    Devereuz, RB
    Julius, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 374A - 374A
  • [6] Regression of electrocardiographic left ventricular hypertrophy by Losartan versus atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
    Okin, PM
    Devereux, RB
    Jern, S
    Kjeldsen, SE
    Julius, S
    Nieminen, MS
    Snapinn, S
    Harris, KE
    Aurup, P
    Edelman, JM
    Dahlöf, B
    CIRCULATION, 2003, 108 (06) : 684 - 690
  • [7] A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy
    Anis, AH
    Sun, HY
    Singh, S
    Woolcott, J
    Nosyk, B
    Brisson, M
    PHARMACOECONOMICS, 2006, 24 (04) : 387 - 400
  • [8] A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
    Aslam H. Anis
    Huiying Sun
    Sonia Singh
    John Woolcott
    Bohdan Nosyk
    Marc Brisson
    PharmacoEconomics, 2006, 24 : 387 - 400
  • [9] Losartan-versus atenolol-based antihypertensive treatment reduces cardiovascular events especially in elderly patients with hypertension and left ventricular hypertrophy on ECG. The LIFE study
    Olsen, M. H.
    Wachtell, K.
    Dahloef, B.
    Devereux, R. B.
    Ibsen, H.
    Kjeldsen, S. E.
    Lindholm, L. H.
    Nieminen, M. D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 667 - 668
  • [10] Effect of losartan compared to atenolol on cardiovascular mortality and morbidity in high and low risk patients with hypertension and left ventricular hypertrophy - The LIFE study
    Franklin, S
    Wachtell, K
    Papademetriou, V
    Olsen, MH
    Fyhrquist, F
    Ibsen, H
    Julius, S
    Kjeldsen, S
    Dahlof, B
    CIRCULATION, 2003, 108 (17) : 764 - 764
12345